XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND NEW ACCOUNTING STANDARDS (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of disaggregation of revenue
               
    Years Ended
December 31,
 
    2023     2022  
Device sales   $ -     $ 1,164,500  
Licensing fee     82,080       79,188  
Royalty fee     -       24,479  
Equipment     27,299       26,778  
Other     1,369       26,412  
Total   $ 110,748     $ 1,321,357  

 

Major Geographic Locations

 

    Years Ended
December 31,
 
    2023     2022  
U.S. sales   $ 107,134     $ 113,541  
China sales     3,614       1,207,816  
Total   $ 110,748     $ 1,321,357  
Schedule of patents
                       
    Gross
Carrying
Amount
    Accumulated
Amortization
   

Net
Carrying

Value

 
December 31, 2023                        
Patents   $ 98,970     $ (3,751 )   $ 95,219  
Total December 31, 2023   $ 98,970     $ (3,751 )   $ 95,219  
                         
December 31, 2022                        
Patents   $ -     $ -     $ -  
Total December 31, 2022   $ -     $ -     $ -  
Schedule of unrealized loss on investments
                         
    Amortized
Cost
    Unrealized
Gain (Loss)
    Fair
Value
 
December 31, 2023                        
Short-term investments   $ 2,368,608     $ (405 )   $ 2,368,203  
Total June 30, 2023   $ 2,368,608     $ (405 )   $ 2,368,203  
                         
December 31, 2022                        
Short-term investments   $ 6,794,879     $ 36,313     $ 6,831,192  
Total December 31, 2022   $ 6,794,879     $ 36,313     $ 6,831,192  
Schedule of fair value, assets measured on recurring basis
                               
    Carrying Value     Level 1     Level 2     Level 3  
December 31, 2023                                
U.S. Treasury Notes   $ 2,368,203     $ 2,368,203     $ -     $ -  
                                 
December 31, 2022                                
U.S. Treasury Notes   $ 6,831,192     $ 6,831,192     $ -     $ -  
Schedule of antidilutive shares
               
    Years Ended
December 31,
 
    2023     2022  
Warrants     2,662,250       2,662,250  
Stock options     2,281,879       -  
Total     4,944,129       2,662,250